Cost Effectiveness Analysis of Pirfenidone For The Treatment of Mild To Moderate Idiopathic Pulmonary Fibrosis (IPF) Compared To Best Supportive Care And Nintedanib From The Italian NHS Perspective

Pulmonary Fibrosis ◽

Supportive Care ◽

Best Supportive Care ◽

PRO47 COST-EFFECTIVENESS ANALYSIS OF PIRFENIDONE TABLETS IN COMPARISON WITH BEST SUPPORTIVE CARE IN IDIOPATHIC PULMONARY FIBROSIS (IPF) TREATMENT IN TURKEY

Value in Health ◽

10.1016/j.jval.2019.09.2377 ◽

2019 ◽

Vol 22 ◽

pp. S849

Author(s):

E. Erdogan-Ciftci ◽

L. Yanik ◽

B. Akyol Ersoy ◽

K. Safak ◽

P.O. Thuresson

Keyword(s):

Cost Effectiveness ◽

Pulmonary Fibrosis ◽

Supportive Care ◽

Best Supportive Care ◽

OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales

The European Journal of Health Economics ◽

10.1007/s10198-015-0737-2 ◽

2015 ◽

Vol 17 (7) ◽

pp. 911-921 ◽

Cited By ~ 6

Author(s):

Nick Freemantle ◽

Kristin Khalaf ◽

Clara Loveman ◽

Sanja Stanisic ◽

Dmitry Gultyaev ◽

...

Keyword(s):

Cost Effectiveness ◽

Overactive Bladder ◽

Supportive Care ◽

Best Supportive Care ◽

England And Wales ◽

PRO55 COST-EFFECTIVENESS ANALYSIS OF PIRFENIDONE TABLETS COMPARED WITH NINTEDANIB FOR IDIOPATHIC PULMONARY FIBROSIS (IPF) TREATMENT IN TURKEY

Value in Health ◽

10.1016/j.jval.2019.09.2385 ◽

2019 ◽

Vol 22 ◽

pp. S851

Author(s):

E. Erdogan-Ciftci ◽

L. Yanik ◽

B. Akyol Ersoy ◽

K. Safak ◽

P.O. Thuresson

Keyword(s):

Cost Effectiveness ◽

Pulmonary Fibrosis ◽

Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis

The Lancet Global Health ◽

10.1016/s2214-109x(21)00261-8 ◽

2021 ◽

Author(s):

Matthew S Painschab ◽

Racquel Kohler ◽

Stephen Kimani ◽

Wilberforce Mhango ◽

Bongani Kaimila ◽

...

Keyword(s):

Cost Effectiveness ◽

Supportive Care ◽

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Best Supportive Care ◽

Large B Cell Lymphoma ◽

Effectiveness Analysis ◽

Large B Cell

Thiopurine S-Methyltranferase Testing in Idiopathic Pulmonary Fibrosis: A Pharmacogenetic Cost-Effectiveness Analysis

Lung ◽

10.1007/s00408-009-9217-8 ◽

2010 ◽

Vol 188 (2) ◽

pp. 125-132 ◽

Cited By ~ 27

Author(s):

Jared T. Hagaman ◽

Brent W. Kinder ◽

Mark H. Eckman

Keyword(s):

Cost Effectiveness ◽

Pulmonary Fibrosis ◽

Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment

British Journal of Cancer ◽

10.1038/sj.bjc.6603561 ◽

2007 ◽

Vol 96 (2) ◽

pp. 206-212 ◽

Cited By ~ 62

Author(s):

N Starling ◽

D Tilden ◽

J White ◽

D Cunningham

Keyword(s):

Colorectal Cancer ◽

Cost Effectiveness ◽

Supportive Care ◽

Metastatic Colorectal Cancer ◽

Cancer Patients ◽

Best Supportive Care ◽

Chemotherapy Treatment ◽

Effectiveness Analysis ◽

Colorectal Cancer Patients

Cost Effectiveness Analysis of Different Management Strategies between Best Supportive Care and Second-line Chemotherapy for Platinum-resistant or Refractory Ovarian Cancer

Asian Pacific Journal of Cancer Prevention ◽

10.7314/apjcp.2016.17.2.799 ◽

2016 ◽

Vol 17 (2) ◽

pp. 799-805

Author(s):

Phanida Luealon ◽

Nipon Khempech ◽

Apichai Vasuratna ◽

Piya Hanvoravongchai ◽

Piyalamporn Havanond

Keyword(s):

Ovarian Cancer ◽

Cost Effectiveness ◽

Supportive Care ◽

Management Strategies ◽

Best Supportive Care ◽

Second Line ◽

Second Line Chemotherapy ◽

Effectiveness Analysis ◽

Line Chemotherapy

A Cost-Effectiveness Analysis Of Onabotulinumtoxina Verse. Best Supportive Care (bsc) For The Treatment Of Anticholinergic Treatment-Refractory Neurogenic Detrusor Overactivity (ndo)

Value in Health ◽

10.1016/j.jval.2014.08.1329 ◽

2014 ◽

Vol 17 (7) ◽

pp. A470

Author(s):

R. Hamid ◽

C. Loveman ◽

J. Millen ◽

D. Colayco ◽

S. Stanisic ◽

...

Keyword(s):

Cost Effectiveness ◽

Supportive Care ◽

Detrusor Overactivity ◽

Best Supportive Care ◽

Neurogenic Detrusor Overactivity ◽

Effectiveness Analysis ◽

Treatment Refractory

Cost-Effectiveness Analysis of Sorafenib versus Best Supportive Care in Advanced Renal Cell Carcinoma in Spain

SSRN Electronic Journal ◽

10.2139/ssrn.944301 ◽

2006 ◽

Author(s):

Pablo Maroto ◽

Humberto Villavicencio ◽

Carme Pinol ◽

Leyre Urruticoechea

Keyword(s):

Renal Cell Carcinoma ◽

Cost Effectiveness ◽

Supportive Care ◽

Cell Carcinoma ◽

Renal Cell ◽

Best Supportive Care ◽

Advanced Renal Cell Carcinoma ◽

Thiopurine S-Methyltranferase Testing in Idiopathic Pulmonary Fibrosis: A Pharmacogenetic Cost-Effectiveness Analysis.

10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1132 ◽

2009 ◽

Author(s):

JT Hagaman ◽

BW Kinder ◽

MH Eckman

Keyword(s):

Cost Effectiveness ◽

Pulmonary Fibrosis ◽